ESC Premium Access

Validation of CHA2DS2-VA score (excluding female sex) in non-valvular atrial fibrillation patients: a nationwide population-based study

Congress Presentation

About the speaker

Mr Jooyoung Woo

Busan (Korea (Republic of))
0 follower

19 more presentations in this session

Impact of atrial fibrillation detected by implantable cardioverter-defibrillators on future stroke events in patients with heart failure

Speaker: Doctor M. Nakano (Chiba, JP)

Thumbnail

Improvement in ejection fraction predicts heart failure after catheter ablation for atrial fibrillation in patients with left ventricular systolic dysfunction : from the KPAF registry

Speaker: Doctor H. Fujimoto (Nara, JP)

Thumbnail

Association of left atrial fibrosis extent with left ventricular geometric remodeling and diastolic dysfunction in patients with paroxysmal atrial fibrillation

Speaker: Doctor T. Gizatulina (Tyumen, RU)

Thumbnail

Catheter ablation outcome and heart failure hospitalization in atrial fibrillation patients with preserved left ventricular ejection fraction: insights from the Kansai plus atrial fibrillation (KPAF)

Speaker: Doctor N. Tanaka (Osaka, JP)

Thumbnail

Atrial fibrillation in arrhythmogenic right ventricular cardiomyopathy and its association with left atrial volume index

Speaker: Doctor M. Baturova (Lund, SE)

Thumbnail

Access the full session

Poster Session 6 - Epidemiology of atrial fibrillation

Speakers: Mr J. Woo, Doctor M. Nakano, Doctor H. Fujimoto, Doctor T. Gizatulina, Doctor N. Tanaka...
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb